Biodesix (BDSX) Non-Current Assets (2019 - 2026)

Biodesix has reported Non-Current Assets for 8 years, with the latest figure at $53.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 5.11% year-over-year to $53.7 million; the trailing twelve-month figure through Mar 2026 stood at $53.7 million (down 5.11% YoY), and the FY2025 full-year result was $55.0 million, down 4.85% from the prior year.
• Non-Current Assets for Q1 2026 stood at $53.7 million, down from $55.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $59.4 million in Q4 2023, with the low at $34.4 million in Q1 2022.
• Historically, Non-Current Assets has averaged $51.7 million across 5 years, with a median of $55.3 million in 2025.
• Annual changes were most pronounced in 2023 — Non-Current Assets soared 50.14% — and 2025, when it declined 5.8%.
• Biodesix's Non-Current Assets stood at $39.6 million in 2022, then soared by 50.14% to $59.4 million in 2023, then declined by 2.78% to $57.8 million in 2024, then decreased by 4.85% to $55.0 million in 2025, then slipped by 2.24% to $53.7 million in 2026.
• The last three Non-Current Assets figures came in at $53.7 million (Q1 2026), $55.0 million (Q4 2025), and $55.3 million (Q3 2025), per Business Quant data.